Literature DB >> 26809973

[Cannabis as a therapeutic agent: Focal topic].

L Radbruch1,2, M Schäfer3,4.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26809973     DOI： 10.1007/s00482-015-0086-1

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  5 in total

1.  Medical use of cannabis products: Lessons to be learned from Israel and Canada.

Authors:  J Ablin; P A Ste-Marie; M Schäfer; W Häuser; M-A Fitzcharles
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 2.  Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.

Authors:  S Tafelski; W Häuser; M Schäfer
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 3.  [Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].

Authors:  M Mücke; C Carter; H Cuhls; M Prüß; L Radbruch; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 4.  Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials.

Authors:  M-A Fitzcharles; C Baerwald; J Ablin; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 5.  [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].

Authors:  F Petzke; E K Enax-Krumova; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107
  5 in total
  2 in total

Review 1.  [Cannabinoid therapy in practice].

Authors:  T Rasche; D Emmert; C Stieber; M Mücke; R Conrad
Journal:  Urologe A       Date:  2018-05       Impact factor: 0.639

Review 2.  Cannabinoids in Pain Management and Palliative Medicine.

Authors:  Winfried Häuser; Mary-Ann Fitzcharles; Lukas Radbruch; Frank Petzke
Journal:  Dtsch Arztebl Int       Date:  2017-09-22       Impact factor: 5.594
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.